To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

IA bupivacaine with tenoxicam versus morphine for postop arthroscopic meniscectomy pain

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
June 2016

IA bupivacaine with tenoxicam versus morphine for postop arthroscopic meniscectomy pain

Vol: 5| Issue: 6| Number:20| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:1

Comparison of intra-articular bupivacaine-morphine with bupivacaine-tenoxicam combinations on post-operative analgesia in patients with arthroscopic meniscectomy: a prospective, randomised study

Int Orthop. 2016 Mar;40(3):601-5

Contributing Authors:
S Sanel O Arpaz K Unay I Turkmen S Simsek E Ugutmen

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

240 patients undergoing arthroscopic partial meniscectomy were randomized to either a combination of 0.5% bupivacaine 100mg + 22mL tenoxicam 20mg, or a combination of 0.5% bupivacaine 10 mg + 22mL morphine 2mg. The purpose of this study was to compare the two treatments for their efficacy in postoperative pain control and safety during the first 24 postoperative hours. The findings indicated that ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue